SCHEMBL5925577

SCHEMBL5925577

CCc1c(N)ccc(C(N)=O)c1OC

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NNMT P40261 1/20 0.39
▸ LTB4R Q15722 1/20 0.36
▸ LTB4R2 Q9NPC1 1/20 0.36
▸ MAPT P10636 2/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ NR1I2 O75469 1/20 0.36
▸ LMNA P02545 1/20 0.36
▸ CHRM2 P08172 1/20 0.36
▸ CYP3A4 P08684 1/20 0.36
▸ ADRA2A P08913 1/20 0.36
▸ OPRK1 P41145 1/20 0.36
▸ HTR2B P41595 1/20 0.36
▸ SLC6A3 Q01959 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ HDAC6 Q9UBN7 1/20 0.36
▸ TSHR P16473 2/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ GAA P10253 1/20 0.35
▸ HPGD P15428 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acetic Acid SCHEMBL5929455 0.95 LTB4R (0.37) NNMTLTB4RLTB4R2MAPTMEN1
SCHEMBL5925600 0.87 TDP1 (0.44) MAPTMEN1CYP3A4KMT2AKDM4E
SCHEMBL7594740 0.85 NNMT (0.40) NNMTLTB4RLTB4R2MAPTMEN1
SCHEMBL15648429 0.80 NNMT (0.44) NNMTMAPTKDM4EALDH1A1GAA
SCHEMBL27656498 0.80 PARP1 (0.39) NNMTMAPTMEN1NR1I2LMNA
SCHEMBL29443121 0.79 NNMT (0.43) NNMTMAPTMEN1KMT2AKDM4E
SCHEMBL22904902 0.79 NNMT (0.43) NNMTMAPTMEN1KMT2AKDM4E
SCHEMBL29443122 0.79 NNMT (0.43) NNMTMAPTMEN1KMT2AKDM4E
SCHEMBL28925024 0.78 NNMT (0.40) NNMTMAPTMEN1KMT2AKDM4E
SCHEMBL11039311 0.78 NNMT (0.52) NNMTMAPTMEN1KMT2ATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060110743-A1 Drug evolution: drug design at hot spots KONISHI YASUO 2006-05-25 — — US disclosed
WO-2002095393-A2 DRUG EVOLUTION: DRUG DESIGN AT HOT SPOTS NATIONAL RESEARCH COUNCIL OF CANADA (CA) 2002-11-28 — — WO disclosed
Send feedback